Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 5/20 | 0.49 |
| ▸ | HTR3A | P46098 | 1/20 | 0.46 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | PAK4 | O96013 | 4/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
| ▸ | TYMS | P04818 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MAT2A | P31153 | 1/20 | 0.41 |
| ▸ | AURKA | O14965 | 1/20 | 0.41 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL432071 | 0.78 | PDE5A (0.62) | PDE5AHTR3AHRH4PKMTYMS | |
| SCHEMBL5595129 | 0.76 | PDE5A (0.52) | PDE5AHTR3AHRH4PKMTYMS | |
| Hydrochloric Acid SCHEMBL7278529 | 0.76 | PDE5A (0.53) | PDE5AHTR3AHRH4PKMTYMS | |
| SCHEMBL5082461 | 0.75 | CSF1R (0.51) | HRH4KDRKMT2A | |
| SCHEMBL148298 | 0.74 | PDE5A (0.65) | PDE5AHTR3AHRH4MAT2A | |
| SCHEMBL2590769 | 0.73 | RAD52 (0.68) | PDE5AHTR3AHRH4PKMKDM4E | |
| SCHEMBL3638867 | 0.73 | PDE5A (0.73) | PDE5AHTR3AHRH4PKMTYMS | |
| SCHEMBL9921364 | 0.69 | LMNA (0.72) | PDE5ASMN1; SMN2KDM4EALDH1A1HPGD | |
| SCHEMBL7260498 | 0.69 | CNR1 (0.54) | PDE5AHTR3AHRH4 | |
| SCHEMBL15530102 | 0.69 | KDR (0.64) | KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1418896-A2 | ADMINISTRATION OF PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF PREMATURE EJACULATION | Vivus, Inc. (US) | 2004-05-19 | — | — | EP | claimed |
| WO-2003000343-A2 | ADMINISTRATION OF PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF PREMATURE EJACULATION | VIVUS, INC. (US) | 2003-01-03 | — | — | WO | claimed |
| EP-2804603-A1 | BETA-CELL REPLICATION PROMOTING COMPOUNDS AND METHODS OF THEIR USE | President and Fellows of Harvard College (US) | 2014-11-26 | — | — | EP | disclosed |
| WO-2013106547-A1 | BETA-CELL REPLICATION PROMOTING COMPOUNDS AND METHODS OF THEIR USE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2013-07-18 | — | — | WO | disclosed |
| EP-1956906-A2 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF MEDICAL CONDITIONS | CombinatoRx, Incorporated (US) | 2008-08-20 | — | — | EP | disclosed |
| EP-1551416-A4 | METHOD FOR TREATING ERECTILE DYSFUNCTION AND INCREASING LIBIDO IN MEN | UNIMED PHARMACEUTICALS INC (US) | 2008-04-23 | — | — | EP | disclosed |
| EP-1868590-A2 | METHOD OF INCREASING TESTOSTERONE AND RELATED STEROID CONCENTRATIONS IN WOMEN | Unimed Pharmaceuticals, Inc. (US) | 2007-12-26 | — | — | EP | disclosed |
| WO-2007056457-A2 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF MEDICAL CONDITIONS | COMBINATORX, INCORPORATED (US) | 2007-05-18 | — | — | WO | disclosed |
| WO-2006113242-A2 | METHOD OF INCREASING TESTOSTERONE AND RELATED STEROID CONCENTRATIONS IN WOMEN | UNIMED PHARMACEUTICALS, INC. (US) | 2006-10-26 | — | — | WO | disclosed |
| EP-1404343-A4 | THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES | SOLVAY PHARMACEUTICALS INC (US) | 2006-08-02 | — | — | EP | disclosed |
| EP-1551416-A2 | METHOD FOR TREATING ERECTILE DYSFUNCTION AND INCREASING LIBIDO IN MEN | Unimed Pharmaceuticals, Inc. (US) | 2005-07-13 | — | — | EP | disclosed |
| WO-2003002123-A2 | THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF HORMONE DEFICIENCIES | SOLVAY PHARMACEUTICALS, INC. (US) | 2003-01-09 | — | — | WO | disclosed |
| WO-2003000343-A2 | ADMINISTRATION OF PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF PREMATURE EJACULATION | VIVUS, INC. (US) | 2003-01-03 | — | — | WO | disclosed |
| EP-1027054-A4 | LOCAL ADMINISTRATION OF PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION | VIVUS INC (US) | 2002-11-04 | — | — | EP | disclosed |
| EP-1237577-A2 | TRANSMUCOSAL COMPOSITION CONTAINING A PHOSPHODIESTERASE INHIBITOR FOR THE TREATMENT OF ERECTILE DYSFUNCTION | Vivus, Inc. (US) | 2002-09-11 | — | — | EP | disclosed |
| WO-2002017927-A1 | METHOD FOR TREATING ERECTILE DYSFUNCTION AND INCREASING LIBIDO IN MEN | UNIMED PHARMACEUTICALS, INC. (US) | 2002-03-07 | — | — | WO | disclosed |
| WO-2001070211-A2 | L-ARGININE AND PHOSPHODIESTERASE (PDE) INHIBITOR SYNERGISM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-09-27 | — | — | WO | disclosed |
| WO-2001041807-A2 | TRANSMUCOSAL COMPOSITION CONTAINING A PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION | VIVUS, INC. (US) | 2001-06-14 | — | — | WO | disclosed |
| EP-1027054-A1 | LOCAL ADMINISTRATION OF PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION | Vivus, Inc. (US) | 2000-08-16 | — | — | EP | disclosed |
| WO-1999021558-A2 | LOCAL ADMINISTRATION OF PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION | VIVUS, INC. (US) | 1999-05-06 | — | — | WO | disclosed |